Research Focus

Former Employee. Medicine; Research Stdy Asst II

Recent additions – View all

1. Phase I evaluation of sequential doxorubicin + gemcitabine then ifosfamide + paclitaxel + cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract

   Journal Article

   Dodd, P. M.; Mccaffrey, J. A.; Hilton, S.; Mazumdar, M.; Herr, H.; Kelly, W. K.; Icasiano, E.; Boyle, M. G.; Bajorin, D. F.
   Journal of Clinical Oncology (2000)

   Fulltext@MSK | Save
2. Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinoma

   Journal Article

   Dodd, P. M.; Mccaffrey, J. A.; Mazumdar, M.; Icasiano, E.; Higgins, G.; Herr, H.; Bajorin, D. F.
   Investigational New Drugs (2000)

   Fulltext@MSK | Save
3. Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: Final report of a phase II trial evaluating two dosing schedules

   Journal Article

   Bajorin, D. F.; Mccaffrey, J. A.; Dodd, P. M.; Hilton, S.; Mazumdar, M.; Kelly, W. K.; Herr, H.; Scher, H. I.; Icasiano, E.; Higgins, G.
   Cancer (2000)

   Fulltext@MSK | Save